Overview

Observational Prospective Study on Patients Treated With Norditropin®

Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
0
Participant gender:
All
Summary
This observational study is conducted globally. The aim of the study is to investigate the effectiveness and safety of real-life treatment with Norditropin®. The study population will consist of children and adults who are on treatment with Norditropin® in accordance with normal clinical practice.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novo Nordisk A/S
Criteria
Inclusion Criteria:

- Judged by the physician as per the Norditropin® label

Exclusion Criteria:

- Judged by the physician as per the Norditropin® label